Our cooperative trials are underpinned by strong partnerships with key research groups locally and globally.
ANZGOG has long been a member of the Gynecologic Cancer InterGroup (GCIG) ensuring significant international clinical trials have been conducted in Australia and New Zealand. The GCIG has grown to 26 member countries including Europe, the Americas and Asia.
We also have strong partnerships with key research groups in the UK, USA, Canada and Singapore.
These relationships benefit women in Australia and New Zealand with faster access to new treatments as they are able to take part in large scale, global clinical trials.
Home grown ANZGOG studies are now being conducted internationally. OUTBACK, an ANZGOG cervical cancer study has recruited patients in the USA, China, Saudi Arabia and Singapore and as well as Australia and New Zealand.
Keeping up to date
Each year ANZGOG investigators take part in international meetings to ensure they are abreast of latest treatments and ideas. These include:
- American Society of Clinical Oncology (ASCO)
- European Society of Medical Oncology (ESMO)
- AACR – American Association for Cancer Research
- IGCS – International Gynecologic Cancer Society
International investigators are invited to speak at the ANZGOG Annual Scientific Meeting annually and to take part in other ANZGOG activities and research.
ANZGOG collaborates with many universities, research institutes and hospitals in Australia and New Zealand. Our clinical trials are conducted with a number of operating centres including the NHMRC Clinical Trials Centre and BaCT.
ANZGOG Chair, Associate Professor Alison Brand, is a member of the Advisory Council of the Clinical Oncology Society of Australia [COSA] and Chief Executive, Alison Evans, is a member of the Executive Officers Network of the Cancer Clinical Trials Groups, supported by COSA.
Many ANZGOG trials are conducted cooperatively with other clinical trials groups such as Psycho-oncology Cooperative group (PoCoG), Urogenital and Prostate Group (ANZUP), Breast Cancer Trials, and Gastrointestinal Trials Group (AGITG).